Latest Breaking News On - Aleksandra rachitskaya - Page 1 : comparemela.com

Cleveland Clinic expert shares eye safety tips for viewing 2024 Total Eclipse

Cleveland Clinic expert shares eye safety tips for viewing 2024 Total Eclipse
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Aleksandra rachitskayaCleveland clinic cole eye instituteCleveland clinicCole eye

Real-world study investigates effects of GLP-1 agonists on diabetic retinopathy

Real-world study investigates effects of GLP-1 agonists on diabetic retinopathy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Eamonn dreisbachBymichela cimberleAleksandra rachitskayaNovo nordisk

What is your approach for treating GA with concomitant neovascular AMD?

What is your approach for treating GA with concomitant neovascular AMD?
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesRoche genentechAbbvie allerganChristine klimanskisIveric bioAleksandra rachitskayaNathanc steinleRetina networkApellis pharmaceuticalsOcular therapeutixCover story

Geographic Atrophy Treatment Breakthrough, Strengthened Doses Headline Historic 2023 for Ophthalmology

Chief among a flurry of clinical advances in retina disease this year were the FDA approvals of complement inhibitors for GA and a higher-dose aflibercept for diabetic retinopathy. What comes next?

United statesStanford universityCleveland clinicChristinen kayIapocec hani salehi hadIapocec apellisIapocec aleksandra rachitskayaIapocec jean francois korobelnikW lloyd clarkMarcoa zarbinIapocec charles wykoffIapocec dianaArshad khananiAleksandra rachitskayaIapocec arshad khananiCampbellp aflibercept

Aleksandra Rachitskaya, MD: Effect of GLP-1 Agonists on Diabetic Retinopathy

Presented at AAO 2023, a retrospective study found no statistically significant difference in retinopathy worsening between GLP-1 RAs and SGLT2 inhibitors.

San franciscoUnited statesAleksandra rachitskayaAmerican academy of ophthalmologyCole eye instituteAnnual american academyCleveland clinic